Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients--findings from the International Verapamil SR/Trandolapril Study (INVEST)

American Heart Journal
Rhonda M Cooper-DeHoffINVEST Investigators

Abstract

People of Hispanic origin are the fastest growing ethnic minority in the United States and often have hypertension and other comorbidities which increase the risk associated with coronary artery disease (CAD). An analysis of the 8045 Hispanic patients enrolled in INVEST was conducted, and comparisons were made to the 14,531 non-Hispanic patients. INVEST was a prospective, randomized, open, blinded end point study in CAD patients with hypertension. After 61,835 patient-years of follow-up, treatment with either a verapamil sustained release (SR) or atenolol antihypertensive strategy resulted in greater blood pressure control in Hispanic patients, and Hispanic patients were at significantly lower risk of experiencing a nonfatal myocardial infarction, nonfatal stroke, or death (hazard ratio [HR] 0.87, 95% CI 0.78-0.97). Hispanic ethnicity was associated with an increase (HR 1.19, 95% CI 1.04-1.36), and randomization to the verapamil SR strategy was associated with a decrease (HR 0.85, 95% CI 0.76-0.95), in the risk of new-onset diabetes. Use of trandolapril in the verapamil SR strategy was associated with reduced risk of new-onset diabetes, whereas increasing doses of atenolol and hydrochlorothiazide in the atenolol strategy were a...Continue Reading

Associated Clinical Trials

References

Jul 18, 1991·The American Journal of Medicine·C K Francis
Nov 24, 1993·JAMA : the Journal of the American Medical Association·P D SorlieE Rogot
Sep 30, 1996·The American Journal of Medicine·K Jamerson, V DeQuattro
Jan 20, 2000·The New England Journal of Medicine·UNKNOWN Heart Outcomes Prevention Evaluation Study InvestigatorsG Dagenais
Jan 16, 2002·JAMA : the Journal of the American Medical Association·Earl S FordWilliam H Dietz
Feb 16, 2002·Hypertension·Carlos LorenzoSteven Haffner
Dec 20, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatm
Jul 2, 2003·Plastic and Reconstructive Surgery·Rollin K Daniel
Jul 10, 2003·JAMA : the Journal of the American Medical Association·Ihab Hajjar, Theodore A Kotchen
Oct 9, 2003·JAMA : the Journal of the American Medical Association·K M Venkat NarayanDavid F Williamson
Dec 6, 2003·Hypertension·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Mar 24, 2004·Hypertension·Paolo VerdecchiaCarlo Porcellati

❮ Previous
Next ❯

Citations

Jan 19, 2013·American Journal of Public Health·John M RuizTimothy B Smith
May 16, 2012·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Nicolas J Guzman
Dec 30, 2014·Progress in Cardiovascular Diseases·Patrick T CampbellHector O Ventura
Dec 29, 2010·Médecine sciences : M/S·Mustapha LkhiderMichèle Ollivier-Bousquet
Nov 11, 2009·Expert Review of Cardiovascular Therapy·Rhonda M Cooper-DeHoffCarl J Pepine
Jan 29, 2016·Diabetes Research and Clinical Practice·Yulia KhodnevaMonika M Safford
Mar 19, 2011·Journal of the American Society of Hypertension : JASH·Keith C FerdinandEdgar A Jaimes
Sep 16, 2009·Preventive Cardiology·Philip R Liebson
Apr 11, 2008·Preventive Cardiology·Juan M ArandaJuan M Aranda
Oct 5, 2011·The American Journal of Medicine·Eugenio Cersosimo, Nicolas Musi
Sep 12, 2007·The American Journal of Cardiology·Stevo Julius
Feb 24, 2015·Advances in Chronic Kidney Disease·Fátima Rodriguez, Keith C Ferdinand
Mar 24, 2012·Diabetes·Guanlan XuAnath Shalev
Apr 4, 2017·The Journal of Clinical Endocrinology and Metabolism·Ti YinKai-Wei Katherine Wang
Sep 12, 2007·Hypertension·Karen L MargolisUNKNOWN Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group
Apr 27, 2019·Current Hypertension Reports·Isac C Thomas, Matthew A Allison
Jan 23, 2018·Current Opinion in Endocrinology, Diabetes, and Obesity·Lance Thielen, Anath Shalev
Jul 11, 2018·Nature Medicine·Fernando OvalleAnath Shalev
Sep 5, 2021·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Alireza MalayeriKambiz A Angali

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.